Clinical Trial Update: Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

A post-marketing commitment study update for Selara (e.g., a hypertension-related trial) indicating completion with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Selara (nihcard or unspecified)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension | Status: COMPLETED | Results posted: 2014-01-08